The Bill & Melinda Gates Foundation has introduced groundbreaking portable ultrasound technology. Anita Zaidi, president of Gender Equality at the Foundation, announced this development at the WomenLift Health Global Conference 2024 in Dar es Salaam, Tanzania.
Zaidi highlighted the critical need for accessible diagnostic tools in regions with limited healthcare infrastructure, pointing out that nearly 300,000 women and over four million newborns die annually due to pregnancy-related complications, predominantly in low- and middle-income countries.
The innovative ultrasound devices, compact and equipped with artificial intelligence capabilities, aim to revolutionize prenatal care by enabling early detection of life-threatening conditions. Field testing has shown their effectiveness in identifying high-risk pregnancies, surpassing human capabilities in estimating gestational age.
Partnering with stakeholders, the Foundation aims to drive transformative change in maternal and child health outcomes globally through the development of these portable, affordable, and AI-enabled ultrasound devices.
In addition to the ultrasound technology, the Foundation introduced Vaccine Microneedle Array Patches (VMAPs), offering a solution to traditional vaccine administration challenges. Early trials have demonstrated their effectiveness in safely delivering vaccines, potentially eliminating barriers to immunization in regions with limited access to cold chain requirements and trained healthcare workers.
Zaidi also emphasized the transformative potential of next-generation diagnostic systems, such as low-cost tests and Extreme Volume Manufacturing (EVM) test strips, in identifying life-threatening diseases faster and more affordably, particularly in resource-limited settings.
Furthermore, Zaidi highlighted the importance of innovation in contraceptive technology to address the unmet needs of women worldwide. Promising innovations, such as DMPA-SC and potential monthly pills, patches, and injectables, offer hope for improving contraceptive access and empowering women to make informed choices about their reproductive health.
The introduction of these innovative technologies underscores the Foundation’s commitment to advancing healthcare and reducing maternal and child mortality in Africa and beyond.
Source: News Agency of Nigeria
